between healthy non-obese women and obese insulin resistant women. 
Obesity is associated with metabolic and cardiovascular risk factors including type 2 diabetes, hypertension, and dyslipidemia (1) (2) (3) (4) . A subset of obese subjects has been identified that appears to be protected against obesityrelated metabolic abnormalities (5) (6) (7) (8) (9) (10) . These subjects, termed metabolically healthy but obese (MHO), are relatively insulin sensitive and have a rather favorable cardiovascular risk profile (5) (6) (7) (8) (9) (10) . Although the existence of MHO individuals has been recognized, a few studies have examined in details the metabolic characteristics associated with their protective profile (5) (6) (7) (8) (9) (10) (11) (12) . While MHO individuals appear to have a more favorable cardiovascular risk profile than insulinresistant obese (IRO) individuals, they show early signs of atherosclerosis as compared with lean subjects, which could not be explained by alterations in cardiovascular risk factors (11) . Among the factors that may account for the early atherosclerosis, insulinlike growth factor-1 (IGF-1) is a plausible candidate because low plasma IGF-I concentrations are associated with type 2 diabetes; insulin resistance (14) (15) (16) , and increased risk of coronary artery disease (17) (18) (19) (20) (21) (22) (23) . To further characterize the protective profile of MHO individuals, we compared clinical characteristics including cardiovascular risk factors, plasma IGF-1 levels, and intima-media thickness (IMT) of the common carotid of a group of MHO women from a cohort of nondiabetic Italian Caucasians with those of two age-matched groups comprising healthy non-obese or IRO women.
RESEARCH DESIGN AND METHODS
The study group consisted of 73 non-obese (BMI <27 kg/m 2 ) and 80 obese women (BMI >30 kg/m 2 ), recruited by announcements in the Universities of Rome and Catanzaro areas. The inclusion criteria were: age 19-48 years, absence of diabetes, absence of known inflammatory disease or pathologies affecting glucose metabolism. Sixty-eight women in the cohort used oral contraceptives while the remaining had regular menses. Subjects underwent anthropometrical evaluation, a 75 g oral glucose tolerance test, and a euglycemic-hyperinsulinemic clamp as previously described (24) . Glucose disposal (M) was calculated as the mean rate of glucose infusion during the last 60 min of the examination and expressed as milligrams per minute per kilogram fat-free mass (M FFM ). IMT of the common carotid artery was measured by high resolution B-mode ultrasound using an ATL-HDI 3000 system equipped with a 5 MHz linear array transducer, as described (25) . The protocol was approved by the ethical committees and informed written consent was obtained from all participants. The investigations were performed in accordance with the principles of the Declaration of Helsinki.
Plasma insulin and IGF-I concentrations were determined by a chemiluminescence-based assay.
Relationships between variables were sought by stepwise multivariate linear regression analysis.
RESULTS -Because insulin sensitivity is a continuous trait, there is no objective definition of insulin resistance. Therefore, the 80 obese subjects were stratified into quartile based on their M FFM values, and women were defined as MHO if their M FFM value was in the upper quartile (>13.2 mg/min x kgFFM; n = 20). Women with M FFM values in the two lower quartiles (<9.9 mg/min x kgFFM; n = 40) were defined as IRO. A control group of 80 non-obese women was included in the study. Clinical characteristics of the three study groups are shown in Table 1 . No differences in age, body mass index (BMI), fat mass, and HDL cholesterol were observed between MHO and IRO individuals. By definition, insulin-stimulated glucose disposal was higher in MHO subjects who also exhibited significant lower lean body mass, fasting and 2-h post-challenge plasma glucose, fasting insulin, triglycerides, systolic and diastolic blood pressure, and carotid IMT as compared with IRO individuals. No differences in age, lean body mass, total cholesterol, triglycerides, fasting and 2-h post-challenge plasma glucose, fasting insulin, and insulin-stimulated glucose disposal were observed between non-obese and MHO subjects (Table 1) . However, MHO women had a less favorable risk profile as compared with non-obese women with a significant higher waist circumference, fat mass, blood pressure, and carotid IMT, and lower concentration of HDL cholesterol and IGF-1. As expected, IRO individuals had a high-risk metabolic and cardiovascular profile than non-obese subjects ( (13, 26) , was lower in MHO as compared with IRO women. Waist circumference was the strongest risk factor associated with IMT in a stepwise multivariate regression analysis. It is likely that free fatty acids and adipokines such as tumor necrosis factor-α, and interleukin-6 which are predominantly secreted from visceral fat and affect vasculature (27) (28) (29) (30) may be responsible for the strong relationship between central obesity and early atherosclerosis. Interestingly, we found that plasma IGF-1 levels were independently associated with carotid IMT, suggesting that low IGF-1 levels could contribute to early atherosclerosis observed in IRO and MHO women as compared with non-obese women. IGF-1 plays an important role in endothelial cells stimulating nitric oxide production (31) (32) (33) . Moreover, low-tissue IGF-1 levels and reduced IGF-1 receptor expression have been found in atherosclerotic plaques (34) . We also found that insulin-stimulated glucose disposal was independently associated with carotid IMT. This finding is consistent with previous studies supporting the concept that insulin sensitivity rather than plasma insulin levels is associated with early atherosclerosis in nondiabetic individuals (24, 35) . Given the relatively small sample size of this study, replication studies are required to assess the applicability of our conclusions to other sets of obese patients. Data are means ± SD. Differences of continuous variables between two groups were compared using unpaired Student's t. BMI: body mass index; SBP = systolic blood pressure; DBP = diastolic blood pressure.
